• Catheter Precision closed a private placement on July 15, 2026, issuing 3,470 shares of Series C-3 Convertible Preferred Stock for USD 3.47 million.
• Preferred shares carry a USD 1,000 stated value; holders can convert into common stock at USD 0.63 per share, subject to a USD 0.35 floor.
• Conversion is capped by a 4.99% beneficial ownership limit, with an option to raise it to 9.99% on 61 days’ notice.
• Net proceeds earmarked for working capital, loan repayment, general corporate purposes; Dawson James Securities served as placement agent.
• Issuance relied on Section 4(a)(2) and Rule 506(b) exemptions; the related S-1 resale registration was declared effective July 10, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Catheter Precision Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-023639), on July 15, 2026, and is solely responsible for the information contained therein.